The EATRIS-Plus Staff Exchange Programme brings postdoctoral researcher Vipin Kumar to the Sahlen group at SciLifeLab, to help uncover the role of long non-coding RNA in gene regulation.
The link was found in a Norwegian mother-child cohort study of breastmilk and confirmed in zebrafish models.
Since its release 20 years ago, JASPAR has provided researchers with access to regularly updated and experimentally curated transcription factor binding profiles. The 10th update of JASPAR now expands this widely used resource even further.
Biswajyoti Sahu, Marieke Kuijjer and Anthony Mathelier have each been awarded funding as part of the Norwegian Cancer Society’s annual main call.
As part of Forskningsdagene, representatives from NCMM gave visiting students and families insight into working with zebrafish in the lab.
Researchers have found a way to make pancreatic cells from completely different cell types. This will be an important tool for accelerating the discovery of new treatments of pancreatic cancer.
The 12th annual Nordic EMBL Partnership brought together members from all four Nordic nodes to Espoo, Finland on 11-14 September 2023.
Sissel Eikvar joined NCMM in August as the new health, safety and environment-coordinator.
Charlotte Boccara is awarded 1.5 million euros for the project SleepCog. The aim is to determine how important sleep is for the healthy development of the brain.
The Kuijjer group present PORCUPINE, a computational tool for pinpointing drivers of cancer heterogeneity that may guide personalized cancer treatment.
A large, international collaboration has led to the discovery of the first genetic variant associated with more severe disease progression in patients with multiple sclerosis.
Researchers at NCMM have demonstrated the mechanisms behind the activation of Aurora B, a central conductor of cell division. Their findings can lay the foundations for developing new cancer drugs.
On the 14th to 15th of June, NCMM and Associate Investigators gathered at Strömstad Spa, Sweden, for two days of excellent scientific talks and networking.
The NCMM annual report for 2022 is now published online
This May NorMIC celebrated the 10th workshop in a series that has established it as an important Nordic platform for biomedical researchers to gain scientific knowledge on optical microscopy.
The Nordic EMBL Partnership for Molecular Medicine gathered in Helsinki to celebrate the signing of a renewed 10-year agreement between EMBL and the Universities of Oslo, Helsinki, Århus and Umeå.
The Seahorse XFe96 is now up and running as a shared instrument at NCMM. Two external groups from Oslo University Hospital are already using the instrument regularly and happy with the results.
NCMM group leader Nikolina Sekulic is coordinating University of Oslo’s participation in the HALRIC program, a multi-institutional initiative aimed at facilitating the cross-border use of research facilities for advanced life science research.
In February, Camila Esguerra visited Dr. Rima Nabbout's laboratory at the Imagine Institute for Genetic Diseases in Paris, France. The visit was made possible by the EATRIS-plus staff exchange programme.
Following a successful evaluation by NCMM’s Scientific Advisory Board (SAB) in February 2023, the Computational Biology and Systems Medicine group led by Marieke Kuijjer has been extended for four years.
By welcoming visiting high school students to her lab, Nikolina Sekulic hopes to motivate more young aspiring students to follow a career in life science research.
NCMM group leader Anthony Mathelier will be the new Associate Director of the Centre, combined with a part-time Professor II position at the Centre for Bioinformatics.
NCMM Associate Investigator Lorena Arranz and colleagues recently published a study demonstrating that a protein involved in balancing inflammation also prevents the development of acute myeloid leukemia. NCMM support played an important part in the execution of the project.
Group leader Sebastian Waszak receives 2 million NOK from the Norwegian Cancer Society for his proposed Pioneer Project. The goal of the project is to find new treatment strategies for DIPG, by establishing novel zebrafish models of this aggressive type of brain tumor.
A new study by the Mathelier group and collaborators has found a way to predict genes that may be associated with cancer by looking at mutations in areas of the genome that do not code for proteins.
